DiseaseID 3546
前列腺腺癌
disease
NCI2016_02D:An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the centr
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Experiment: 1Symptom: 1Target: 12Links: 14
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 3546
- Core Entity Id
- 59764
- Source Entity Count
- 1
- Preferred Name
- Adenocarcinoma of Prostate
- Name Cn
- 前列腺腺癌
- Name Pinyin
- Qian Lie Xian Xian Ai
- Name En
- Adenocarcinoma of Prostate
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Neoplastic Process
- Disgenet Type
- disease
- Mesh Class
- Male Urogenital Diseases; Neoplasms
- Do Class
- disease of anatomical entity; disease of cellular proliferation
- Hpo Class
- Mesh Class Name
- Neoplasms; Male Urogenital Diseases
- Hpo Class Name
- Do Class Name
- disease of anatomical entity; disease of cellular proliferation
- Disease Definition
- NCI2016_02D:An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Adenocarcinoma of Prostate
Role
preferred
Name
Prostate Adenocarcinoma
Role
alias
Cross References
Trusted external identifiers retained for this final record.
Herb
HBDIS000446
Umls
C0007112
Sym Map
SMDE05478
Do Class
DOID:14566DOID:7
Dis Ge Net
C0007112
Umls Sty
T191
Me Sh Class
C04C12
Tcmbank Disease
13956
Itcmdb Generated
ITX-DISEASE-1BB7EEB41948
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Do Class Name
disease of anatomical entity; disease of cellular proliferation
Disease Type
disease
Do Disease Class
disease of anatomical entity; disease of cellular proliferation
Umls Disease Type
Neoplastic Process
Disease Definition
NCI2016_02D:An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.
Me Sh Disease Class
Male Urogenital Diseases; Neoplasms
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Neoplasms; Male Urogenital Diseases
Umls Semantic Type Name
Neoplastic Process